Bob 1 Rabbit Polyclonal Antibody
To Order: garrett@bioworldantibodies.com
Bob 1 Polyclonal Conjugated Antibody |
C46860 |
SAB |
100ul |
EUR 476.4 |
Anti-Bob 1 antibody |
STJ98803 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to Bob 1. |
POU2AF1 Antibody / BOB-1 |
V8023-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V8023-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V8023SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3902-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3902-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3902SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3903-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3903-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3903SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3915-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
V3915-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
V3915SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
V3918-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3918-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V3918SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V7324-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V7324-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V7324IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
V7324SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
HRP-Goat Anti-Rabbit Secondary Antibody |
A12004 |
EpiGentek |
|
|
Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
A12001 |
EpiGentek |
|
|
Polyclonal BOB / GPR15 Antibody (Cytoplasmic Domain) |
AMM05631G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
Polyclonal BOB / GPR15 Antibody (Extracellular Domain) |
AMM05632G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
BOB.1 MonoSpecific Antibody, Unconjugated-20ug |
5450-MSM4-P0 |
EnQuireBio |
20ug |
EUR 279.6 |
BOB.1 MonoSpecific Antibody, Unconjugated-100ug |
5450-MSM4-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC942423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC942423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC942424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC942424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC942425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC942425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF594 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCA2423-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), APC conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCA2424-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), APC conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCA2425-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), APC conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC552423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC552423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC552424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC552424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC552425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC552425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF555 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC612423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC612423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC612424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC612424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC612425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC612425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF660R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCP2423-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), PerCP conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCP2424-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), PerCP conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCP2425-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), PerCP conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCR2423-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), RPE conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCR2424-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), RPE conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCR2425-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), RPE conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC402423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC402423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC402424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC402424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC402425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC402425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF640R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC432423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC432423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC432424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC432424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC432425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC432425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF543 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC052423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC052423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC052424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC052424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC052425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC052425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405M conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC812423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC812423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC812424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC812424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC812425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC812425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680R conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC802423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC802423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC802424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC802424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC802425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC802425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCH2423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCH2423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCH2424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCH2424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCH2425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCH2425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNUB2423-100 |
Biotium |
100uL |
EUR 316.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNUB2423-50 |
Biotium |
50uL |
EUR 486 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), 1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNUB2423-500 |
Biotium |
500uL |
EUR 615.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNUB2424-100 |
Biotium |
100uL |
EUR 316.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNUB2424-50 |
Biotium |
50uL |
EUR 486 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), 1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNUB2424-500 |
Biotium |
500uL |
EUR 615.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNUB2425-100 |
Biotium |
100uL |
EUR 316.8 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNUB2425-50 |
Biotium |
50uL |
EUR 486 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), 1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNUB2425-500 |
Biotium |
500uL |
EUR 615.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Concentration: 0.2mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC042423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC042423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC042424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC042424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC042425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC042425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC682423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC682423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC682424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC682424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC682425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC682425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF568 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC702423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC702423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC702424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC702424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC702425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC702425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF770 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCAP2423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCAP2423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCAP2424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCAP2424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCAP2425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCAP2425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC882423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC882423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC882424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC882424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC882425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC882425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF488A conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC472423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNC472423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC472424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNC472424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC472425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNC472425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF647 conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCB2423-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Biotin conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
BNCB2423-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Biotin conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCB2424-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Biotin conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
BNCB2424-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Biotin conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCB2425-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Biotin conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
BNCB2425-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Biotin conjugate, Concentration: 0.1mg/mL |
Rabbit Polyclonal Antibody to Human Topoisomerase IIα |
TG2011-1 |
TopoGen |
250 units |
EUR 496.8 |
Polyclonal Rabbit anti-sEH |
SEH-1 |
Detroit R&D |
50 uL |
EUR 336 |
Anti-Sumo 1 Rabbit Monoclonal Antibody |
M00631-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal Sumo 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse, Rat. |
Anti-Cytokeratin 1 Rabbit Monoclonal Antibody |
M01639-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal Cytokeratin 1 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
Anti-Integrin beta 1 Rabbit Monoclonal Antibody |
M00772-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal Integrin beta 1 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat. |
Anti-ARG1/Arginase 1 Rabbit Monoclonal Antibody |
M01106-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal ARG1/Arginase 1 Antibody. Validated in IP, WB and tested in Human, Mouse, Rat. |
Anti-MLANA/Mart 1 Rabbit Monoclonal Antibody |
M02033-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal MLANA/Mart 1 Antibody. Validated in IF, WB and tested in Human. |
Anti-DSG1/Desmoglein 1 Rabbit Monoclonal Antibody |
M02655-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal DSG1/Desmoglein 1 Antibody. Validated in IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
Anti-HMGB1/Hmg 1 Rabbit Monoclonal Antibody |
M00066-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal HMGB1/Hmg 1 Antibody. Validated in Flow Cytometry, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
Anti-p27 KIP 1 Rabbit Monoclonal Antibody |
M00173-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Anti-p27 KIP 1 Rabbit Monoclonal Antibody tested for Flow Cytometry, IP, IF, IHC, ICC, WB in Human, Rat |
Anti-MHC class 1 Rabbit Monoclonal Antibody |
M00194-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal MHC class 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
Histone H3K4 Methylation Antibody Panel Pack |
C10005 |
EpiGentek |
|
|
Histone H3K9 Methylation Antibody Panel Pack |
C10006 |
EpiGentek |
|
|
Histone H3K27 Methylation Antibody Panel Pack |
C10007 |
EpiGentek |
|
|
Histone H3K36 Methylation Antibody Panel Pack |
C10008 |
EpiGentek |
|
|
Histone H3K79 Methylation Antibody Panel Pack |
C10009 |
EpiGentek |
|
|
Histone H4K20 Methylation Antibody Panel Pack |
C10012 |
EpiGentek |
|
|
Histone H4 Acetylation Antibody Panel Pack |
C10013 |
EpiGentek |
|
|
Histone H3 Phosphorylation Antibody Panel Pack |
C10014 |
EpiGentek |
|
|
Histone H3R2 Methylation Antibody Panel Pack |
C10015 |
EpiGentek |
|
|
Histone H3R8 Methylation Antibody Panel Pack |
C10016 |
EpiGentek |
|
|
Histone H3R17 Methylation Antibody Panel Pack |
C10017 |
EpiGentek |
|
|
Histone H3R26 Methylation Antibody Panel Pack |
C10018 |
EpiGentek |
|
|
Histone H4R3 Methylation Antibody Panel Pack |
C10019 |
EpiGentek |
|
|
HRP-Goat Anti-Mouse Secondary Antibody |
A12003 |
EpiGentek |
|
|
DNA Methylation Antibody Panel Pack I |
C20000 |
EpiGentek |
|
|
Histone H3 Acetylation Antibody Panel Pack I |
C10010 |
EpiGentek |
|
|
Histone H3 Acetylation Antibody Panel Pack II |
C10011 |
EpiGentek |
|
|
Goat Anti-Rat Secondary Antibody, Biotin Conjugated |
A12002 |
EpiGentek |
|
|
Histone H3 Methylation Antibody Panel Pack I – Active Genes |
C10000 |
EpiGentek |
|
|
Histone H3 Methylation Antibody Panel Pack I – Repression Genes |
C10001 |
EpiGentek |
|
|
Histone H3 Methylation Antibody Panel Pack II – Active Genes |
C10002 |
EpiGentek |
|
|
Histone H3 Methylation Antibody Panel Pack II – Repression Genes |
C10003 |
EpiGentek |
|
|
Histone H3 Methylation Antibody Panel Pack III – Active Genes |
C10004 |
EpiGentek |
|
|
Bob 1 Rabbit Polyclonal Antibody